The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II trial of docetaxel, cisplatin, 5-fluorouracil (TPF) in locally advanced and metastatic squamous cell carcinoma (SCC) of the penis (CRUK/09/001).
Amit Bahl
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Steve Nicholson
No relevant relationships to disclose
Stephen John Harland
No relevant relationships to disclose
John D. Chester
No relevant relationships to disclose
Lisa M. Pickering
Consultant or Advisory Role - Sanofi
Jim Barber
No relevant relationships to disclose
Clare Cruickshank
No relevant relationships to disclose
Stephanie M. Burnett
No relevant relationships to disclose
Rachel Waters
No relevant relationships to disclose
Emma Hall
No relevant relationships to disclose